EP0851760A4 - Interleukin converting enzyme and apoptosis - Google Patents

Interleukin converting enzyme and apoptosis

Info

Publication number
EP0851760A4
EP0851760A4 EP96930620A EP96930620A EP0851760A4 EP 0851760 A4 EP0851760 A4 EP 0851760A4 EP 96930620 A EP96930620 A EP 96930620A EP 96930620 A EP96930620 A EP 96930620A EP 0851760 A4 EP0851760 A4 EP 0851760A4
Authority
EP
European Patent Office
Prior art keywords
apoptosis
converting enzyme
interleukin converting
interleukin
enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96930620A
Other languages
German (de)
French (fr)
Other versions
EP0851760A1 (en
Inventor
Mark Alan Levy
John Gerald Gleason
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0851760A1 publication Critical patent/EP0851760A1/en
Publication of EP0851760A4 publication Critical patent/EP0851760A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EP96930620A 1995-08-31 1996-08-29 Interleukin converting enzyme and apoptosis Withdrawn EP0851760A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US308395P 1995-08-31 1995-08-31
PCT/US1996/013867 WO1997007805A1 (en) 1995-08-31 1996-08-29 Interleukin converting enzyme and apoptosis
US3083 2001-12-06

Publications (2)

Publication Number Publication Date
EP0851760A1 EP0851760A1 (en) 1998-07-08
EP0851760A4 true EP0851760A4 (en) 1998-11-25

Family

ID=21704047

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96930620A Withdrawn EP0851760A4 (en) 1995-08-31 1996-08-29 Interleukin converting enzyme and apoptosis

Country Status (3)

Country Link
EP (1) EP0851760A4 (en)
JP (1) JPH11514345A (en)
WO (1) WO1997007805A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69925581T2 (en) 1998-03-09 2006-04-27 Vertex Pharmaceuticals Inc., Cambridge 1,2-DIAZEPANDERIVATE AS INHIBITORS OF INTERLEUKIN-1BETA CONVERTING ENZYME
DK1064298T3 (en) 1998-03-19 2009-01-19 Vertex Pharma Inhibitors of caspases
US6307049B1 (en) 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
PE20011350A1 (en) 2000-05-19 2002-01-15 Vertex Pharma PROPHARMAC OF AN INHIBITOR OF INTERLEUKIN-1ß CONVERTER ENZYME (ICE)
EP2295054A1 (en) 2004-05-27 2011-03-16 Vertex Pharmaceuticals Incorporated Ice inhibitors for the treatment of autoinflammatory diseases
US9956260B1 (en) 2011-07-22 2018-05-01 The J. David Gladstone Institutes Treatment of HIV-1 infection and AIDS

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0124081A2 (en) * 1983-05-02 1984-11-07 Merck & Co. Inc. New substituted cephalosporin sulfones as antiinflammatory and antidegenerative agents, pharmaceutical compositions containing the same and processes for making them
EP0267723A2 (en) * 1986-11-12 1988-05-18 Merck & Co. Inc. New substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents
WO1995002603A2 (en) * 1993-07-14 1995-01-26 Pharmacia S.P.A. Use of cephem derivatives as anti-metastatic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2266525A (en) * 1992-03-17 1993-11-03 Merck & Co Inc Substituted cephalosporin sulfone compositions useful in the treatment of leukemia

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0124081A2 (en) * 1983-05-02 1984-11-07 Merck & Co. Inc. New substituted cephalosporin sulfones as antiinflammatory and antidegenerative agents, pharmaceutical compositions containing the same and processes for making them
EP0267723A2 (en) * 1986-11-12 1988-05-18 Merck & Co. Inc. New substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents
WO1995002603A2 (en) * 1993-07-14 1995-01-26 Pharmacia S.P.A. Use of cephem derivatives as anti-metastatic agents

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
M. ALPEGIANI ET AL.: "Cephem Sulfones as Inactivators of Human Leukocyte Elastase. 5. 7-alpha-Methoxy- and 7-alpha-Chloro-1,1-dioxocephem 4-Ketones", J. MED. CHEM., vol. 37, no. 23, 1994, pages 4003 - 4019, XP002077984 *
P. E. FINKE ET AL.: "Inhibition of Human Leukocyte Elastase. 4. Selection of a Substituted Cephalosporin (L-658,758) as a Topical Aerosol", J. MED. CHEM., vol. 35, no. 21, 1992, pages 3731 - 3744, XP002077983 *
See also references of WO9707805A1 *

Also Published As

Publication number Publication date
EP0851760A1 (en) 1998-07-08
WO1997007805A1 (en) 1997-03-06
JPH11514345A (en) 1999-12-07

Similar Documents

Publication Publication Date Title
PL328527A1 (en) Inhibitors of interleukin-1beta converting enzyme
HUP9902254A3 (en) Inhibitors of interleukin-1beta converting enzyme
PL318220A1 (en) Inhibitors of interleukin-1 converting enzyme
EP0810875A4 (en) Multifunctional enzyme
AU1399997A (en) Apoptosis inducers
EP0833914A4 (en) Human chemokine beta-11 and human chemokine alpha-1
EP0859779A4 (en) Interleukin converting enzyme and apoptosis
AU6587596A (en) Culture vessel and assembly
EP0811059A4 (en) Human chemokine beta-11 and human chemokine alpha-1
AU5383498A (en) Human chemokine beta-13
ZA9610798B (en) Inhibitors of interleuken-1beta converting enzyme
EP0770141A4 (en) INTERLEUKIN-1 -g(b) CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-1 AND 2
EP0851760A4 (en) Interleukin converting enzyme and apoptosis
GB9505475D0 (en) Enzyme
GB2293288B (en) Conversion between analogue and digital signals
GB9505479D0 (en) Enzyme
IL118404A0 (en) Enzyme degrading rhamnogalacturonane II its preparation and use
GB9623539D0 (en) Enzymes and their use
GB9407484D0 (en) Enzyme
GB9617184D0 (en) Enzyme
AU3617097A (en) Pro-protein converting enzyme
GB9422157D0 (en) Enzyme
AU2525697A (en) Plant enzyme and use thereof
PL328829A1 (en) Enzyme
ZA944857B (en) Interleukin-1beta converting enzyme like apoptosis protease-1 and 2

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980223

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE ES FR GB IT LI NL

A4 Supplementary search report drawn up and despatched

Effective date: 19981006

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE CH DE ES FR GB IT LI NL

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030301